HRT Financial’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

HRT Financial’s Portfolio BCTXW Stock Details BCTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,844	Closed	-$1K	–	3799
2025 Q4	$1K	Buy	+20,844	New	+$1.04K	﹤0.01%	3083
2025 Q3	–	Sell	-21,248	Closed	-$1K	–	2864
2025 Q2	$1K	Buy	+21,248	New	+$1.92K	﹤0.01%	2500

HRT Financial's BCTXW Position: Q1 2026 in Review

HRT Financial sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q1 2026, closing a stake of 20,844 shares — an estimated $1K sold.

HRT Financial first reported a position in BCTXW in Q2 2025 and held it in 2 quarters. The position peaked at $1K in Q4 2025. 0 funds tracked by Wall St. Rank hold BCTXW as of Q1 2026.

HRT Financial reported no remaining BriaCell Therapeutics Corp Warrant position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 20,844 BriaCell Therapeutics Corp Warrant shares in Q1 2026, an estimated $1K.
HRT Financial first reported a position in BriaCell Therapeutics Corp Warrant in Q2 2025 and held it in 2 quarters.
HRT Financial's BriaCell Therapeutics Corp Warrant position peaked at $1K in Q4 2025.
0 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.